Navigation Links
Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
Date:4/24/2009

SAN DIEGO - Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered a new drug combination that significantly hinders tumor growth in neuroblastoma, a childhood cancer. The study was presented today at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO).

By combining a novel multi-kinase inhibitor, vandetanib, with 13-cis-retinoic acid (CRA), a drug often used for severe acne, researchers from the Children's Cancer Hospital at M. D. Anderson found that the two therapies reduced neuroblastoma tumors by 86 percent in pre-clinical tests.

Peter Zage, M.D., Ph.D., who specializes in neuroblastoma at the Children's Cancer Hospital, received this year's Young Investigator Award from ASPHO and was selected to present his research today in a special platform session.

"By itself, vandetanib inhibited tumor growth by two-thirds and decreased blood vessel formation around neuroblastoma tumors in mice," says Zage. "When combined with CRA, the impact was even greater on tumor growth."

Vandetanib blocks a family of endothelial growth factors and receptors that promote tumor growth as well as the RET oncogene, which can signal neuroendocrine cells to develop into neuroblastoma cells. Although commonly used in treatment for neuroblastoma, CRA by itself does not have a significant impact against the childhood cancer. However, it works in combination therapy to differentiate neuroblastoma cells into mature benign neural cells.

Currently, there is a Phase I clinical trial open for children with multiple-relapsed neuroblastoma to further study the new therapy combination. This trial is the first in the world to test vandetanib in children.

Zage says in addition to the pediatric patients enrolled in the Phase I trial, adult patients with lung cancer have received vandetanib and have tolerated the novel drug well.


'/>"/>

Contact: Lindsay Anderson
lindsay.anderson@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. HIV therapy in pregnancy-data support WHO recommendations
3. Family-based treatment more effective than supportive psychotherapy in treating bulimia
4. Trial to Test Gene Therapy for Angina in Women
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
9. New Drug No Substitute for Standard Blood-Clot Therapy
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
(Date:9/17/2014)... Recently, UWDress.com, an innovative company that provides many kinds ... released its 2014 empire waist evening dress ... big sale for these new and beautiful products. All ... from 15 to 65 percent off. , It ... to wear materials. Its elegant items include gold empire ...
(Date:9/17/2014)... September 18, 2014 IntimateRider, an inventor ... adults , has announced that it has entered into ... & Mobility LLC. A primary reason for the deal ... distribution reach is global. About its sales potential, representatives ... to provide you with the latest products on the ...
(Date:9/17/2014)... September 18, 2014 iFitDress.com, a renowned wedding ... of petite evening dresses . All these outfits are ... and discounted shipping costs. , ā€œiFitDress.com is a professional ... gowns. We are now busy selling our new collection of ... place an order above $800 can get free shipping. All ...
(Date:9/17/2014)... September 18, 2014 The National Resident ... Match , a comprehensive analysis of the relationship between ... preferred specialty. The new edition is based on ... specialty for U.S. allopathic medical school senior students and ... be able to provide this new edition of Charting ...
(Date:9/17/2014)... Columbus, Ohio (PRWEB) September 18, 2014 ... cycle management services nationwide, announces today that they ... Fort Wayne Radiology (FWRadiology) in Fort Wayne, Indiana. ... range of billing services encompassing their proprietary suite ... Technology (EBT). EBT improves radiology billing and ...
Breaking Medicine News(10 mins):Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3Health News:Elegant Petite Evening Dresses Introduced By Renowned Supplier iFitDress.com 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 2Health News:ADVOCATE Wins Radiology Billing Agreements with Fort Wayne Radiology 3
... ... 10 NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ), a ... President and Chief Financial Officer will be interviewed live on FOXBusiness.com LIVE on ... www.foxbusiness.com/live on Friday, December 11, 2009 between 12 and ...
... , ... know much about depression , but are highly aware of ... by the National Alliance on Mental Illness (NAMI). ... Web site that includes resources for people of diverse communities. , ...
... that tuberculosis bacteria use to coerce disease-fighting cells to ... line the airways and other surfaces to protect and ... into helping create tubercles: the small, rounded masses characteristic ... their numbers and spread to other locations. ...
... ... Laser-type device to be coupled with Stem Cell Therapy in Novel ... San Diego (PRWEB) December 10, 2009 -- Entest Biomedical Inc. ... with Advanced Light Devices to develop a proprietary laser system. It is anticipated this investigational medical device will ...
... , New report notes that ... could decline by 36 percent , Oak Brook, Ill., ... (ASGE) lauds the recent news of the decline in U.S. colorectal ... that from 1975 to 2000, incidence rates dropped 22 percent and ...
... alcoholic beverages (at least three to four drinks per week, ... 30 percent increased risk of breast cancer recurrence, according to ... be most susceptible to the effects of alcohol on recurrence, ... this study will be presented December 9-13 at the Cancer ...
Cached Medicine News:Health News:NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE 2Health News:Depression Survey: Implications for Diverse Communities 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 3Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 2Health News:Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment 3Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 2Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 3Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 4Health News:Alcohol consumption may increase breast cancer recurrence risk 2
(Date:9/17/2014)... According to a new market research report ... Display, & Microprocessor/MCU), by Application (Imaging, Medical Therapeutics, Diagnosis, ... Global Forecast to 2020", published by MarketsandMarkets, the total ... $56.50 Billion by 2020, growing at a CAGR of ... market data Tables and 71 Figures spread through 312 ...
(Date:9/17/2014)... , Sept. 17, 2014 An analysis ... regarding patients taking Sovaldi® (sofosbuvir), a new and expensive ... shows that over the last several months (May through ... downward trend in Sovaldi utilization. This suggests another surge ... new therapeutic regimens of similar efficacy and shorter duration ...
(Date:9/17/2014)... MORRISTOWN, N.J. , Sept. 17, 2014 /PRNewswire/ ... LLP (MDM&C), today announced that it will serve ... the Benefits and Avoiding the Risks of Healthcare ... 2014 that will examine delivery systems, reimbursement, compliance ... Affordable Care Act. Logo -  ...
Breaking Medicine Technology:Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2
... Conn., Sept 18 Further results from the initial clinical trial ... for varicose veins, will be delivered on Friday, September 25, at ... The device combines mechanical and chemical modalities to accomplish vein treatment ... Steve Elias MD FACS FACPh, Associate Professor of Surgery at Mount ...
... NEWNAN, Ga., Sept. 16 CeloNova BioSciences, Inc. today announced ... the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) conference ... treating liver cancer. Professor Orsi and his colleagues at the ... technique to cut off the blood supply inside liver tumors ...
Cached Medicine Technology:ClariVein(TM) Catheter for Varicose Veins: Further Clinical Trial Results to Be Presented 2New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: